Rengalin Solution oral administration, 100 ml
Category
Cough
Scope of the drug
Respiratory system
Release form
Solution
Manufacturer country
Russia
Package quantity, pcs
one
Rengalin is indicated for use in adults and children from 3 years old.
Productive and unproductive cough with influenza and SARS, acute pharyngitis, laryngotracheitis, acute obstructive laryngitis, chronic bronchitis and other infectious-inflammatory and allergic diseases of the upper and lower respiratory tract.
Name ENG
RENGALIN
Clinical and pharmacological group
Antitussive, anti-inflammatory drug with antibronchoconstrictor action
ATX code
Other antitussives
Dosage
0.12g / 100ml + 0.12g / 100ml + 0.12g / 100ml x 100ml
Structure
Antibodies to bradykinin, affinity purified 0.12 g *, antibodies to histamine, affinity purified 0.12 g *, antibodies to morphine, affinity purified 0.12 g * (* are administered as a mixture of three active aqueous dilutions of the substance, diluted 10012, 10030, 10050 times, respectively). substances: hypromellose - 1 g, maltitol - 6 g, glycerol - 3 g, potassium sorbate - 0.165 g, anhydrous citric acid - 0.02 g, purified water - up to 100 ml.
...
Indications
Acute and chronic respiratory diseases, accompanied by cough and bronchospasm.
Productive and unproductive cough with influenza and SARS, acute pharyngitis, laryngotracheitis, acute obstructive laryngitis, chronic bronchitis and other infectious-inflammatory and allergic diseases of the upper and lower respiratory tract.
INN / Active ingredient
Antibodies to bradykinin, affinity purified, antibodies to histamine, affinity purified, antibodies to morphine, affinity purified
Contraindications
Contraindications
Children under 3 years old.
Increased individual sensitivity to drug components.
Hereditary fructose intolerance (due to the presence of maltitol in the composition).
Carefully
Diabetes.
Storage conditions and periods
At a temperature not higher than 25 degrees.
Expiration date: 3 years
Specifications
Category
Cough
Scope of the drug
Respiratory system
Release form
Solution
Manufacturer country
Russia
Package quantity, pcs
one
Scope of application
Virology
Minimum age from
3 years old
Way of introduction
Through the mouth
Vacation conditions
Without recipe
Volume, ml.
100 ml
Brand name
Materia Medica Holding
The amount of the dosage form in the primary package
100 ml
Primary packaging type
Bottle
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Other antitussives
Anatomical and therapeutic characteristics
R05DB Other antitussives
Dosage form
Oral solution
Packaging
Box
The target audience
Children
Expiration date in days
1095
Package weight, g
120
Mode of application
:
Inside.
At one time - 1-2 teaspoons (5-10 ml) - outside the meal.
It is advisable to keep the solution in the mouth before swallowing for maximum drug effect.
Apply 1-2 teaspoons 3 times a day.
Depending on the severity of the condition in the first three days, the frequency of administration can be increased up to 4-6 times a day.
The duration of therapy depends on the severity of the disease and is determined by the attending physician.
Dosage (volume) of the substance in the preparation
:
Antibodies to bradykinin affinity purified 0.12 g
Antibodies to histamine affinity purified 0.12 g
Affinity purified antibodies to morphine 0.12 g